Ketogenic diet could help people with Parkinson, Cancer, Schizophrenia, Anxiety and Depression

[Universe]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543248/?fbclid=IwAR3JxoNIDArtwKxz7lcsjLk9L7xN45OkY33XDZXZ loY-XK3KE3DvIpA_8xU

[Universe]

It has been demonstrated in animal—and/or human studies—that ketogenic diets and supplements may have metabolism-based therapeutic potential in the treatment of several diseases, such as Alzheimer’s disease (53–57), Parkinson’s disease (54, 58–60), glucose transporter type 1-deficiency syndrome (61–63), amyotrophic lateral sclerosis (60, 64), cancer (44, 58, 65, 66), epilepsy (54, 67, 68), schizophrenia (42, 69–74), anxiety (55, 75–77), autism spectrum disorder (78–81), and depression (69, 77, 82).

Ketogenic diets are high-fat, adequate protein and very low carbohydrate diets that may have an alleviating role on psychiatric diseases (69, 73), likely through bioenergetics, ketone metabolism, and signaling, as well as their effects on, for example, neuronal activity, neurotransmitter balance, and inflammatory processes (43, 52, 83–91).